AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 278: H558-H566, 2000;
0363-6135/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaudet, E.
Right arrow Articles by Head, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaudet, E.
Right arrow Articles by Head, G. A.
Vol. 278, Issue 2, H558-H566, February 2000

Effects of central infusion of ANG II and losartan on the cardiac baroreflex in rabbits

Elisabeth Gaudet, Shirley J. Godwin, and Geoffrey A. Head

Baker Medical Research Institute, Melbourne, Victoria 8008, Australia

The effect of chronic activation or inhibition of central ANG II receptors on cardiac baroreflex function in conscious normotensive rabbits was examined. Animals received a fourth ventricular (4V) infusion of ANG II (30 and 100 ng/h), losartan (3 and 30 µg/h), or Ringer solution (2 µl/h) for 2 wk. After 1 and 2 wk, ANG II (100 ng/h) decreased cardiac baroreflex gain by 20 and 37%, respectively (P = 0.015), whereas losartan (30 µg/h) increased baroreflex gain by 24 and 58%, respectively (P = 0.02). Within 1 wk of the end of the infusions, cardiac baroreflex gain had returned to control. Ringer solution or the lower doses of ANG II or losartan did not modify the cardiac baroreflex function. Blood pressure and heart rate were not altered by any treatment, nor was their variability affected. These data demonstrate a novel long-term modulation of cardiac baroreflexes by endogenous ANG II that is independent of blood pressure level.

blood pressure; angiotensin type 1 receptors; fourth ventricular administration; long-term infusion


This article has been cited by other articles:


Home page
HypertensionHome page
M. C. Laterza, L. D.N.J. de Matos, I. C. Trombetta, A. M.W. Braga, F. Roveda, M. J.N.N. Alves, E. M. Krieger, C. E. Negrao, and M. U.P.B. Rondon
Exercise Training Restores Baroreflex Sensitivity in Never-Treated Hypertensive Patients
Hypertension, June 1, 2007; 49(6): 1298 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Paul, A. Poyan Mehr, and R. Kreutz
Physiology of local Renin-Angiotensin systems.
Physiol Rev, July 1, 2006; 86(3): 747 - 803.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. M. Mousa, L. Gao, K. G. Cornish, and I. H. Zucker
Effects of angiotensin II on autonomic components of nasopharyngeal stimulation in male conscious rabbits
J Appl Physiol, May 1, 2005; 98(5): 1607 - 1611.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Xue, J. Pamidimukkala, and M. Hay
Sex differences in the development of angiotensin II-induced hypertension in conscious mice
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2177 - H2184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Gao, W. Wang, Y.-L. Li, H. D. Schultz, D. Liu, K. G. Cornish, and I. H. Zucker
Sympathoexcitation by central ANG II: Roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2271 - H2279.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
K. Sakai, M. W. Chapleau, S. Morimoto, M. D. Cassell, and C. D. Sigmund
Differential modulation of baroreflex control of heart rate by neuron- vs. glia-derived angiotensin II
Physiol Genomics, December 15, 2004; 20(1): 66 - 72.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Maliszewska-Scislo, T. J. Scislo, and N. F. Rossi
Effect of blockade of endogenous angiotensin II on baroreflex function in conscious diabetic rats
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1601 - H1611.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. P. O'Hagan, K. A. Skogg, and J. B. Stevenson
AT1 receptor block does not affect arterial baroreflex during pregnancy in rabbits
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H1996 - H2005.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
O. Baltatu, B. J. Janssen, G. Bricca, R. Plehm, J. Monti, D. Ganten, and M. Bader
Alterations in Blood Pressure and Heart Rate Variability in Transgenic Rats With Low Brain Angiotensinogen
Hypertension, February 1, 2001; 37(2): 408 - 413.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Morimoto, M. D. Cassell, T. G. Beltz, A. K. Johnson, R. L. Davisson, and C. D. Sigmund
Elevated Blood Pressure in Transgenic Mice With Brain-Specific Expression of Human Angiotensinogen Driven by the Glial Fibrillary Acidic Protein Promoter
Circ. Res., August 17, 2001; 89(4): 365 - 372.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online